MedTrace Logo

Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease

NCT01035567 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-12-03

No results posted yet for this study

Summary

The purpose of the study is to assess the safety and efficacy of hybrid revascularization in comparison with coronary artery bypass grafting among patients with multivessel coronary artery disease.

Conditions

Interventions

PROCEDURE

Hybrid revascularization

First stage: implantation of the internal mammary artery into LAD in MIDCAB/TECAB procedure Second stage: PCI with drug eluting stents in other coronary arteries qualified for revascularization within 36 hours after surgery

PROCEDURE

Coronary Artery Bypass Grafting

Coronary artery bypass grafting with sternotomy on or off the pump at discretion of the operator.

Sponsors & Collaborators

  • Ministry of Science and Higher Education, Poland

    collaborator OTHER_GOV

  • Silesian Centre for Heart Diseases

    lead OTHER

Principal Investigators

  • Marian Zembala, PhD · Silesian Center for Heart Disease

  • Mariusz Gasior, PhD · Silesian Center for Heart Disease

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2013-05-31
Completion
2013-10-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01035567 on ClinicalTrials.gov